Amwill Healthcare shares to debut on BSE SME platform today. Here’s what GMP indicates

The shares of Amwill Healthcare will debut on the BSE SME platform on Wednesday and the GMP trends indicate a muted listing for the company. The shares have no GMP in the grey market, ahead of the debut, which could mean a flat-to-negative premium over the issue price.

The company has offered its shares in the IPO at Rs 111 apiece. The total issue size included 54.03 lakh shares, of which 44.03 lakh shares were offloaded by existing investors.

The IPO received a modest subscription from investors 5 times, led by institutional bidding. The category reserved for QIB investors was booked 7.8 times, followed by NII at 5.66 times and retail investors at 4.77 times.

Amwill Healthcare is a derma-cosmetic development company, associated with contract manufacturers, distributor and third party product development agencies, which has enabled us in developing capabilities, in manufacturing, packaging and distribution.

The core focus of the company is on development of problem solving dermatological, cosmeceutical and aesthetical products, and therefore to direct all its efforts towards product formulation and development, it has outsourced key functions such as manufacturing, prototype development and distribution to third parties, for effective management and execution.

The product portfolio of our company is divided into two categories, namely, development and contract manufacturing of generic dermatological solutions and developing and formulating solutions to specific dermatological problems.Majority of the products marketed by the company were developed by its promoter and managing director, Anand Gandhi, in the capacity of a sole proprietor of Amwill Healthcare.India’s $14 billion beauty and personal care industry is on a roll thanks to online sales of beauty products, premiumisation, and an inclination towards organic and ethical brands.

According to a report by research firm Euromonitor International, last year, with the presence of online retailers like Nykaa.com and Amazon.com, the beauty and personal care products category crossed $400 million in internet sales up from $100 million in 2014.

The cosmetics sector will likely continue to expand, reflecting the changing market trends. In this era of digital dominance, the businesses that provide customers with a highly personalised experience will be the real trendsetters in the cosmetics sector.

Boddess’ focus on Al, AR, and skin and makeup diagnostic tools, for instance, has fuelled the growth of the beauty business. Personalised packaging is currently popular, with items like name-engraved lipstick and intensely hydrating moisturisers.

Additionally, throughout the coming year, the brand will become more palpable, ensuring encounters both online and offline.